phenyl acetate has been researched along with Respiratory Distress Syndrome in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Sanghai, N; Tranmer, GK | 1 |
Aimbire, F; Almeida-Oliveira, AR; Aquino-Junior, JCJ; Brito, AA; Castro-Faria-Neto, HC; Consolim-Colombo, FM; Damaceno-Rodrigues, NR; Davino-Chiovatto, JE; MacKenzie, B; Oliveira, APL; Oliveira-Junior, MC; Rigonato-Oliveira, NC; Santos-Dias, A; Silva, AP; Vieira, RP | 1 |
Chen, T; Jin, F; Li, W; Liu, X; Ma, L; Nan, Y; Wang, R; Zhao, Y | 1 |
Borgia, JF; Burhop, KE; Eiznhamer, DA; Flavin, MT; Jesmok, GJ; Nelson, DJ; Xu, ZQ | 1 |
Dorinsky, PM; Nathan, RA; Nelson, HS; Philpot, E; Prillaman, BA; Stauffer, JL; Waitkus-Edwards, K; Yancey, SW | 1 |
Manack, L; Skolnick, AA | 1 |
Kobayashi, T; Matsumoto, Y; Nishizuka, K; Shibata, K; Tashiro, K; Yamamoto, K; Yamashita, M | 1 |
Chikazawa, Y; Furue, S; Hori, Y; Kuwabara, K; Maekawa, N; Matsukawa, A; Mikawa, K; Nishina, K; Obara, H; Ono, T; Shiga, M; Ueno, M; Yoshinaga, M | 1 |
Hori, Y; Koike, K; Ono, T; Yamamoto, Y | 1 |
Furue, S; Hori, Y; Kuwabara, K; Matsukawa, A; Mikawa, K; Nishina, K; Obara, H; Ono, T; Shiga, M; Teshirogi, I; Tomita, Y; Ueno, M; Yoshinaga, M | 1 |
Chen, SM; Chiang, BN; Kuo, CD; Wang, JH; Wu, WG | 1 |
1 trial(s) available for phenyl acetate and Respiratory Distress Syndrome
Article | Year |
---|---|
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
Topics: Acetates; Administration, Inhalation; Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Patient Selection; Quinolines; Reproducibility of Results; Respiratory Distress Syndrome; Respiratory Function Tests; Rhinitis, Allergic, Perennial; Sleep Wake Disorders; Sulfides; Treatment Outcome; Wakefulness | 2005 |
10 other study(ies) available for phenyl acetate and Respiratory Distress Syndrome
Article | Year |
---|---|
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms.
Topics: Acetates; Age Factors; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Cytokine Release Syndrome; Cytokines; Drug Repositioning; Humans; Leukotriene Antagonists; NF-kappa B; Obesity; Quinolines; Respiratory Distress Syndrome; Severity of Illness Index; Sex Factors; Signal Transduction; Sulfides | 2020 |
Montelukast, Leukotriene Inhibitor, Reduces LPS-Induced Acute Lung Inflammation and Human Neutrophil Activation.
Topics: Acetates; Animals; Bronchoalveolar Lavage; Capillary Permeability; Cyclopropanes; Cytokines; Humans; Leukocyte Count; Leukotriene Antagonists; Lipopolysaccharides; Lung; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Neutrophil Activation; Neutrophils; NF-kappa B; Pneumonia; Quinolines; Receptors, Leukotriene B4; Respiratory Distress Syndrome; Sulfides; Time Factors; Vascular Endothelial Growth Factor A | 2019 |
3,5,4'-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway.
Topics: Acetates; Animals; Capillary Permeability; Cells, Cultured; Inflammation Mediators; Lipopolysaccharides; Lung; Male; MAP Kinase Signaling System; Mice; Respiratory Distress Syndrome; Resveratrol; Sirtuin 1; Stilbenes | 2015 |
Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal models.
Topics: Acetates; Animals; Blood-Air Barrier; Capillary Permeability; Disease Models, Animal; Endotoxins; Guinea Pigs; Hydroxybenzoates; Lipopolysaccharides; Lung; Neutrophils; Prodrugs; Respiratory Distress Syndrome; Sheep | 2004 |
Science reporters hear wide range of recent data at 12th annual conference.
Topics: Acetates; Aged; AIDS Vaccines; American Medical Association; Amines; Animals; Anticonvulsants; beta-Cyclodextrins; Cells, Cultured; Clinical Trials as Topic; Cochlear Implants; Complementary Therapies; Constriction, Pathologic; Coronary Artery Bypass; Cyclodextrins; Cyclohexanecarboxylic Acids; Depressive Disorder; Drug Therapy, Combination; Epilepsy; Extracorporeal Membrane Oxygenation; Felbamate; Fetus; Gabapentin; gamma-Aminobutyric Acid; Genetic Therapy; Health Care Costs; HIV Infections; Humans; Hyperlipoproteinemia Type II; Lamotrigine; Muscle, Smooth; National Institutes of Health (U.S.); Oxygen; Phenylcarbamates; Propylene Glycols; Respiration, Artificial; Respiratory Distress Syndrome; Triazines; United States; Vascular Surgical Procedures | 1993 |
Mechanism of acute lung injury caused by inhalation of fabric protector and the effect of surfactant replacement.
Topics: Acetates; Alkanes; Animals; Inhalation Exposure; Lung; Lung Injury; Prospective Studies; Pulmonary Surfactants; Random Allocation; Rats; Respiratory Distress Syndrome; Solvents | 1998 |
Crucial role of group IIA phospholipase A(2) in oleic acid-induced acute lung injury in rabbits.
Topics: Acetates; Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extravascular Lung Water; Group II Phospholipases A2; Indoles; Interleukin-8; Keto Acids; Leukotriene B4; Lung; Lung Compliance; Male; Oleic Acid; Oxygen; Phospholipases A; Phospholipids; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Thromboxane A2 | 1999 |
Group IIA phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion.
Topics: Acetates; Animals; Disease Models, Animal; Humans; Indoles; Intestines; Keto Acids; Liver; Lung; Male; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Respiratory Distress Syndrome | 2000 |
Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection.
Topics: Acetates; Animals; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Enzyme Inhibitors; Group II Phospholipases A2; Indoles; Keto Acids; Male; Oleic Acid; Phospholipases A; Phospholipases A2; Pulmonary Surfactants; Rabbits; Respiratory Distress Syndrome | 2001 |
Proton nuclear magnetic resonance studies of plasma to determine metabolic status of patients with adult respiratory distress syndrome.
Topics: 3-Hydroxybutyric Acid; Acetates; Acetoacetates; Arteries; Blood Proteins; Chromatography, High Pressure Liquid; Humans; Hydroxybutyrates; Lactates; Lactic Acid; Lung; Magnetic Resonance Spectroscopy; Phenylalanine; Pulmonary Artery; Respiratory Distress Syndrome; Veins | 1989 |